Literature DB >> 2476310

Antisense oligonucleotide inhibition of encephalomyocarditis virus RNA translation.

S Sankar1, K C Cheah, A G Porter.   

Abstract

We report the inhibition of encephalomyocarditis virus (EMCV) RNA translation in cell-free rabbit reticulocyte lysates by antisense oligonucleotides (13-17-base oligomers) complementary to (a) the viral 5' non-translated region, (b) the AUG start codon and (c) the coding sequence. Our results demonstrate that the extent of translation inhibition is dependent on the region where the complementary oligonucleotides bind. Non-complementary and 3'-non-translated-region-specific oligonucleotides had no effect on translation. A significant degree of translation inhibition was obtained with oligonucleotides complementary to the viral 5' non-translated region and AUG initiation codon. Digestion of the oligonucleotide:RNA hybrid by RNase H did not significantly increase translation inhibition in the case of 5'-non-translated-region-specific and initiator-AUG-specific oligonucleotides; in contrast, RNase H digestion was necessary for inhibition by the coding-region-specific oligonucleotide. We propose that (a) 5'-non-translated-region-specific oligonucleotides inhibit translation by affecting the 40S ribosome binding and/or passage to the AUG start codon, (b) AUG-specific oligonucleotides inhibit translation initiation by inhibiting the formation of an active 80S ribosome and (c) the coding-region-specific oligonucleotide does not prevent protein synthesis because the translating 80S ribosome can dislodge the oligonucleotide from the EMCV RNA template.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2476310     DOI: 10.1111/j.1432-1033.1989.tb14987.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  9 in total

Review 1.  Genetic engineering of plants for virus resistance.

Authors:  F Gadani; L M Mansky; R Medici; W A Miller; J H Hill
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

2.  Expression, purification, and properties of recombinant encephalomyocarditis virus RNA-dependent RNA polymerase.

Authors:  S Sankar; A G Porter
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

3.  Amplification of the full-length hepatitis A virus genome by long reverse transcription-PCR and transcription of infectious RNA directly from the amplicon.

Authors:  R Tellier; J Bukh; S U Emerson; R H Purcell
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-30       Impact factor: 11.205

4.  Regulation of CAT protein by ribozyme and antisense mRNA in transgenic mice.

Authors:  D L Sokol; R J Passey; A G MacKinlay; J D Murray
Journal:  Transgenic Res       Date:  1998-01       Impact factor: 2.788

5.  Effects of antisense oligodeoxynucleotide hybridization on in vitro translation of potato virus Y RNA.

Authors:  C Levis; M Tronchet; M Meyer; J Albouy; S Astier-Manifacier
Journal:  Virus Genes       Date:  1992-01       Impact factor: 2.332

6.  An anti-lymphocytic choriomeningitis virus ribozyme expressed in tissue culture cells diminishes viral RNA levels and leads to a reduction in infectious virus yield.

Authors:  Z Xing; J L Whitton
Journal:  J Virol       Date:  1993-04       Impact factor: 5.103

7.  Intracellular availability of unmodified, phosphorothioated and liposomally encapsulated oligodeoxynucleotides for antisense activity.

Authors:  A R Thierry; A Dritschilo
Journal:  Nucleic Acids Res       Date:  1992-11-11       Impact factor: 16.971

8.  Target-specific arrest of mRNA translation by antisense 2'-O-alkyloligoribonucleotides.

Authors:  H E Johansson; G J Belsham; B S Sproat; M W Hentze
Journal:  Nucleic Acids Res       Date:  1994-11-11       Impact factor: 16.971

Review 9.  Antisense inhibition of virus infections.

Authors:  R E Kilkuskie; A K Field
Journal:  Adv Pharmacol       Date:  1997
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.